RESPONSE: re: preclinical and clinical development of cyclin-dependent kinase modulators
J Natl Cancer Inst
.
2000 Jul 19;92(14):1185.
doi: 10.1093/jnci/92.14.1185.
Authors
AM Senderowicz
1
,
EA Sausville
Affiliation
1
A. M. Senderowicz, Molecular Therapeutics Unit, Oral and Pharyngeal Cancer Branch, National Institute of Dental and Craniofacial Research, Bethesda, MD.
PMID:
10904097
DOI:
10.1093/jnci/92.14.1185
No abstract available